MiniMed Group, Inc. (NASDAQ:MMED) will release its first quarter earnings report before the opening

MiniMed Group, Inc. (MMED) will report Q1 earnings on Sept. 1. Analysts expect 9 cents/share, down f

The FDA authorized Abbott's Libre Duo 10 Day, the first wearable tracking both glucose and keton

NORTHRIDGE, Calif., Aug. 25, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabete

MMED's MiniMed Flex is now shipping in the U.S. with Abbott's 15-day Instinct sensor, pairing discre

MiniMed Flex™ with Instinct, made by Abbott, combines discreet design, up to 15 days of sensor wear

Medtronic could finally be on the cusp of a long-awaited turnaround.

MiniMed expands Flex access to Medicare beneficiaries, widening availability of its app-controlled p

MiniMed Group, a Medtronic spin-off, is rated a buy with an FY 2027 price target of $19, implying 15

NORTHRIDGE, Calif., July 22, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabete

NORTHRIDGE, Calif., July 20, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabete

MiniMed appoints Alcon CEO David Endicott and Linnea Burman to its Board of Directors PR Newswire NO

David Endicott, Chief Executive Officer of Alcon, brings global healthcare leadership and public com

MMED expands its European diabetes tech reach with Abbott sensor integration, boosting user flexibil

MiniMed automated insulin delivery and smart MDI systems can now be paired with Instinct and Instinc

People with type 1 or insulin-requiring type 2 diabetes in the U.S. can now wear MiniMed's smallest

Wells Fargo analyst Larry Biegelsen maintains Minimed Group (NASDAQ:MMED) with a Overweight and l

Dow falls 296 points. Navitas Semi rises on partnership with Nvidia. Other gainers: ABVX, MMED, KELY

MiniMed Group NASDAQ: MMED reported record fiscal 2026 revenue and outlined a slate of product launc

Minimed Group (NASDAQ:MMED) reported quarterly losses of $(0.68) per share which missed the analyst

Agreement builds on the companies' ongoing partnership to expand choice and simplify diabetes ma

Agreement builds on the companies' ongoing partnership to expand choice and simplify diabetes manage

Continued momentum in Q4, with net sales of $837 million growing 16% as reported and 9% organic year

Following this week's launch of MiniMed Go™, MiniMed will bring hands-on demonstrations of the syste

NORTHRIDGE, Calif., May 26, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes

MiniMed study results show MiniMed 780G delivering consistent glycemic outcomes across sensors, rein

B of A Securities analyst Travis Steed maintains Minimed Group (NASDAQ:MMED) with a Buy and lower

Benchmark analyst Bruce Jackson initiates coverage on Minimed Group (NASDAQ:MMED) with a Buy rati

MiniMed Group, Inc. ((MiniMed, NASDAQ:MMED), a global leader in insulin delivery, announced Health C

On April 24, 2026, Medtronic plc ("Medtronic"), the parent company of MiniMed Group, Inc. (&

US stock futures rise, Vicor Corp shares dip 2.2% in pre-market trading after beating earnings and s

Goldman Sachs calls Minimed Group a compelling play on the diabetes market and a potentially profit

MiniMed shows improved pipeline and valuation upside as insulin pump adoption grows despite rising c

Wall Street analysts changed outlook on top stocks. See ratings changes for MTRN, AQN, SXT, MMED, an

Barclays analyst Matt Miksic initiates coverage on Minimed Group (NASDAQ:MMED) with a Overweight

William Blair analyst Steven Lichtman initiates coverage on Minimed Group (NASDAQ:MMED) with a Ou

Citigroup analyst Joanne Wuensch initiates coverage on Minimed Group (NASDAQ:MMED) with a Buy rat

Piper Sandler analyst Matt O'Brien initiates coverage on Minimed Group (NASDAQ:MMED) with a N

Mizuho analyst Anthony Petrone initiates coverage on Minimed Group (NASDAQ:MMED) with a Outperfor

Wells Fargo analyst Larry Biegelsen initiates coverage on Minimed Group (NASDAQ:MMED) with a Over

Morgan Stanley analyst Kallum Titchmarsh initiates coverage on Minimed Group (NASDAQ:MMED) with a

Evercore ISI Group analyst Daniel Markowitz initiates coverage on Minimed Group (NASDAQ:MMED) wit

B of A Securities analyst Travis Steed initiates coverage on Minimed Group (NASDAQ:MMED) with a B

Top analysts changed outlook on top names. For full view of changes, see analyst ratings page. Consi

BTIG analyst Marie Thibault initiates coverage on Minimed Group (NASDAQ:MMED) with a Buy rating a

MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced U.S. Food and Drug A

MiniMed Group, Inc. (MiniMed; Nasdaq: MMED), a global leader in diabetes management, will begin trad